Why does chest pain present atypically in women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Chest Pain Presentation Differs in Women

The premise that chest pain is "atypical" in women is actually a misconception based on male-centered symptom definitions—women present with chest pain just as frequently as men (87-92% of cases), but they more commonly report additional accompanying symptoms alongside chest pain. 1

The Core Misunderstanding

The term "atypical" is fundamentally problematic because it uses male symptom patterns as the reference standard. Women are not presenting atypically; rather, the medical definition of "typical" was derived predominantly from male patients. 1, 2

  • Chest pain remains the predominant symptom in women with acute coronary syndrome (ACS), occurring with equal frequency to men (89.5% vs 87% in patients ≤55 years; 91-92% across all ages). 1
  • The 2021 ACC/AHA guidelines explicitly recommend avoiding the term "atypical chest pain" and instead describing presentations as "cardiac," "possibly cardiac," or "non-cardiac" to prevent misclassification of symptoms as benign. 1, 3

What Actually Differs: Accompanying Symptoms

Women are significantly more likely to present with chest pain plus additional symptoms rather than chest pain alone:

  • Jaw and neck pain: 10% in women vs 4% in men 1
  • Nausea/vomiting: 32% in women vs 23% in men 1
  • Epigastric symptoms, palpitations, and pain between shoulder blades: 61.9% in women vs 54.8% in men 1
  • Back pain: More common in postmenopausal women (63-72%) 4
  • Dyspnea, fatigue, and shortness of breath: More frequently reported by women 1

Why This Pattern Exists

Biological Factors

Women with ACS are typically 8-10 years older than men at presentation, with median age 69 vs 62 years. 1 This age difference relates to:

  • Loss of estrogen's vascular protective effects after menopause (antioxidative, vasodilatory, prostaglandin regulatory, and smooth muscle proliferation inhibitory properties). 1
  • Higher rates of microvascular dysfunction rather than obstructive epicardial coronary disease, which may produce different symptom patterns. 5

Hormonal Influences

Premenopausal women actually report atypical chest symptoms more frequently than postmenopausal women (57% vs 22-31%), independent of age. 4 Postmenopausal women more commonly report:

  • Substernal chest pain (78-83% vs 44% in premenopausal) 4
  • Indigestion-like discomfort (50-56% vs 22%) 4
  • Sudden fatigue (89% vs 53-61%) 4

Pathophysiologic Differences

Women have weaker correlation between symptoms and significant luminal obstruction at coronary angiography compared to men. 1 This reflects:

  • Higher prevalence of microvascular angina (MVA) in women—chest pain with ischemia on stress testing but no obstructive CAD on angiography. 5
  • Endothelial dysfunction and abnormal coronary reactivity as primary mechanisms rather than fixed stenoses. 5

Clinical Consequences of This Misunderstanding

The mislabeling of women's symptoms as "atypical" leads to systematic underdiagnosis and undertreatment:

  • Women are less likely to undergo coronary angiography (73.8% vs 84.3% in men) even when presenting with chest pain. 1
  • Traditional risk assessment tools underestimate cardiac risk in women and misclassify them as having nonischemic chest pain. 1
  • Women present to hospital approximately 1 hour later after symptom onset (median 300 vs 238 minutes), potentially due to both patient and provider delays in recognizing cardiac etiology. 1
  • Women receive less aggressive treatment including lower rates of antiplatelets, beta-blockers, statins, and revascularization. 1

Key Algorithmic Approach

When evaluating chest pain in women:

  1. Assume cardiac etiology until proven otherwise—women are at high risk for underdiagnosis. 1

  2. Obtain 12-lead ECG within 10 minutes and measure high-sensitivity cardiac troponin immediately. 1, 3

  3. Specifically ask about accompanying symptoms: jaw/neck pain, nausea, fatigue, dyspnea, back pain, palpitations, and epigastric discomfort. 1

  4. Use sex-specific troponin thresholds (>16 ng/L for women vs >34 ng/L for men with hs-cTnI), which reclassify 30% of women as having STEMI who would be missed with universal thresholds. 1

  5. Do not dismiss symptoms based on "atypical" features—the presence of additional symptoms alongside chest pain is the norm in women, not an exception. 1, 2

Common Pitfalls to Avoid

  • Never use nitroglycerin response as a diagnostic criterion—esophageal spasm and other conditions respond similarly. 1, 3
  • Do not assume younger women or those without traditional risk factors are low-risk—women are underdiagnosed across all age groups. 1
  • Avoid attributing symptoms to anxiety or non-cardiac causes without objective testing, as this perpetuates diagnostic delays. 1
  • Recognize that sharp or pleuritic pain does not exclude ACS—13% of patients with pleuritic features have acute myocardial ischemia. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Evaluation of Chest Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Gender and microvascular angina.

Journal of thrombosis and thrombolysis, 2011

Related Questions

Can jaw pain be a sign of myocardial infarction (heart attack)?
Do obese patients have atypical chest pain presentations during a myocardial infarction (heart attack)?
What are the signs, symptoms, and treatment of myocardial infarction (MI) in females?
What are the symptoms and management of a heart attack in women, especially those with a history of cardiovascular disease?
Can throat pain be a symptom of myocardial infarction (heart attack)?
In a woman with recurrent implantation failure and suspected immune‑mediated factors (elevated uterine natural‑killer cell activity), can Intralipid (20 % fat emulsion) be used as an adjunct around embryo transfer, and what is the recommended dosing regimen?
How should I measure and interpret fasting insulin levels?
What ocular findings are expected in patients with candidemia?
When should a C‑peptide test be ordered in adults and how are fasting and stimulated C‑peptide results interpreted for diabetes type differentiation, hypoglycemia evaluation, and assessment of residual β‑cell function?
Is it normal for the scrotum to become narrow and align parallel to the penis during erection, whereas it was previously more rounded?
According to the OLYMPIA trial, what is the recommended adjuvant olaparib regimen (dose, duration, monitoring, and alternatives if contraindicated) for early‑stage high‑risk HER2‑negative breast cancer patients with a germline BRCA1 or BRCA2 pathogenic variant who have completed surgery, radiation, and anthracycline‑taxane‑based chemotherapy (and endocrine therapy if hormone‑receptor‑positive)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.